+1 800 783 4636

UC-ll® Maintains Growth in Joint Health Sector in 2016

IRI scan data from 2015 showed that UC-ll® had unprecedented growth in the joint health sector of the supplement and vitamin marketplace. In fact, that growth was at 61% over a 52 week period, far outperforming the general joint health market which declined by 15%. Though glucosamine and chondroitin still dominated, UC-ll® was predicted to grow even more as a contender due to its small, single dose requirement. Read More